Loading...
Limited Capability for Testing Mycobacterium tuberculosis for Susceptibility to New Drugs
We surveyed availability of phenotypic drug susceptibility testing for drug-resistant Mycobacterium tuberculosis in Europe. Of 27 laboratories, 17 tested for linezolid, 11 for clofazimine, 9 for bedaquiline, and 6 for delamanid during 2019. Our findings indicate that testing capacity for newer and r...
Saved in:
| Published in: | Emerg Infect Dis |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Centers for Disease Control and Prevention
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7920658/ https://ncbi.nlm.nih.gov/pubmed/33622487 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid2703.204418 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|